Jushi Holdings (JUSHF) Total Current Liabilities (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Total Current Liabilities came in at $75.1 million in Q1 2026, up 23.94% year-on-year from $60.6 million in Q1 2025, and up 13.45% on a QoQ basis from $66.2 million in Q4 2025.
Jushi Holdings (JUSHF) Total Current Liabilities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Total Current Liabilities data on file, last reported at $75.1 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 23.94% year-over-year to $75.1 million in Q1 2026; TTM through Mar 2026 was $75.1 million, a 23.94% increase from a year earlier, with the FY2025 full-year figure at $66.2 million, down 3.93% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $75.1 million, up from $66.2 million in the prior quarter.
- Over the last five years, Total Current Liabilities for JUSHF reached as high as $228.7 million in Q3 2022 and fell as low as $60.6 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $110.3 million across 5 years, with a median of $108.4 million in 2022.
- On a YoY basis, Total Current Liabilities climbed as much as 56.47% in 2025 and fell as far as 63.13% in 2025.
- Year by year, Total Current Liabilities stood at $107.6 million in 2022, then jumped by 50.95% to $162.5 million in 2023, then sank by 57.59% to $68.9 million in 2024, then retreated by 3.93% to $66.2 million in 2025, then increased by 13.45% to $75.1 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $75.1 million in Q1 2026, $66.2 million in Q4 2025, and $109.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 75.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.09 Mn |
| Dec 31, 2025 | 66.19 Mn |
| Sep 30, 2025 | 109.19 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Mar 31, 2025 | 60.58 Mn |
| Dec 31, 2024 | 68.90 Mn |
| Sep 30, 2024 | 69.78 Mn |
| Jun 30, 2024 | 73.73 Mn |
| Mar 31, 2024 | 164.30 Mn |
| Dec 31, 2023 | 162.46 Mn |
| Sep 30, 2023 | 116.26 Mn |
| Jun 30, 2023 | 127.62 Mn |
| Mar 31, 2023 | 115.29 Mn |
| Dec 31, 2022 | 107.63 Mn |
| Sep 30, 2022 | 228.67 Mn |
| Jun 30, 2022 | 156.58 Mn |
| Dec 31, 2021 | 83.93 Mn |